Your browser doesn't support javascript.
loading
Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
Chandele, Anmol; Sewatanon, Jaturong; Gunisetty, Sivaram; Singla, Mohit; Onlamoon, Nattawat; Akondy, Rama S; Kissick, Haydn Thomas; Nayak, Kaustuv; Reddy, Elluri Seetharami; Kalam, Haroon; Kumar, Dhiraj; Verma, Anil; Panda, HareKrushna; Wang, Siyu; Angkasekwinai, Nasikarn; Pattanapanyasat, Kovit; Chokephaibulkit, Kulkanya; Medigeshi, Guruprasad R; Lodha, Rakesh; Kabra, Sushil; Ahmed, Rafi; Murali-Krishna, Kaja.
Afiliação
  • Chandele A; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, India.
  • Sewatanon J; Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Gunisetty S; Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Singla M; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Onlamoon N; Department of Pediatrics, Division of Infectious Disease, and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Akondy RS; Pediatric Pulmonary Division, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
  • Kissick HT; Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Nayak K; Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Reddy ES; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Kalam H; Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Kumar D; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, India.
  • Verma A; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, India.
  • Panda H; Immunology Group, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, India.
  • Wang S; Immunology Group, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, India.
  • Angkasekwinai N; Pediatric Pulmonary Division, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
  • Pattanapanyasat K; ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, India.
  • Chokephaibulkit K; Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Medigeshi GR; Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Lodha R; Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Kabra S; Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Ahmed R; Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Murali-Krishna K; Pediatric Pulmonary Division, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
J Virol ; 90(24): 11259-11278, 2016 Dec 15.
Article em En | MEDLINE | ID: mdl-27707928
Epidemiological studies suggest that India has the largest number of dengue virus infection cases worldwide. However, there is minimal information about the immunological responses in these patients. CD8 T cells are important in dengue, because they have been implicated in both protection and immunopathology. Here, we provide a detailed analysis of HLA-DR+ CD38+ and HLA-DR- CD38+ effector CD8 T cell subsets in dengue patients from India and Thailand. Both CD8 T cell subsets expanded and expressed markers indicative of antigen-driven proliferation, tissue homing, and cytotoxic effector functions, with the HLA-DR+ CD38+ subset being the most striking in these effector qualities. The breadth of the dengue-specific CD8 T cell response was diverse, with NS3-specific cells being the most dominant. Interestingly, only a small fraction of these activated effector CD8 T cells produced gamma interferon (IFN-γ) when stimulated with dengue virus peptide pools. Transcriptomics revealed downregulation of key molecules involved in T cell receptor (TCR) signaling. Consistent with this, the majority of these CD8 T cells remained IFN-γ unresponsive even after TCR-dependent polyclonal stimulation (anti-CD3 plus anti-CD28) but produced IFN-γ by TCR-independent polyclonal stimulation (phorbol 12-myristate 13-acetate [PMA] plus ionomycin). Thus, the vast majority of these proliferating, highly differentiated effector CD8 T cells probably acquire TCR refractoriness at the time the patient is experiencing febrile illness that leads to IFN-γ unresponsiveness. Our studies open novel avenues for understanding the mechanisms that fine-tune the balance between CD8 T cell-mediated protective versus pathological effects in dengue. IMPORTANCE: Dengue is becoming a global public health concern. Although CD8 T cells have been implicated both in protection and in the cytokine-mediated immunopathology of dengue, how the balance is maintained between these opposing functions remains unknown. We comprehensively characterized CD8 T cell subsets in dengue patients from India and Thailand and show that these cells expand massively and express phenotypes indicative of overwhelming antigenic stimulus and tissue homing/cytotoxic-effector functions but that a vast majority of them fail to produce IFN-γ in vitro Interestingly, the cells were fully capable of producing the cytokine when stimulated in a T cell receptor (TCR)-independent manner but failed to do so in TCR-dependent stimulation. These results, together with transcriptomics, revealed that the vast majority of these CD8 T cells from dengue patients become cytokine unresponsive due to TCR signaling insufficiencies. These observations open novel avenues for understanding the mechanisms that fine-tune the balance between CD8-mediated protective versus pathological effects.
Assuntos
Linfócitos T CD8-Positivos/imunologia; Citotoxicidade Imunológica; Vírus da Dengue/efeitos dos fármacos; Subpopulações de Linfócitos T/imunologia; Transcriptoma/imunologia; ADP-Ribosil Ciclase 1/genética; ADP-Ribosil Ciclase 1/imunologia; Adolescente; Anticorpos/farmacologia; Antígenos CD28/antagonistas & inibidores; Antígenos CD28/genética; Antígenos CD28/imunologia; Complexo CD3/genética; Complexo CD3/imunologia; Linfócitos T CD8-Positivos/efeitos dos fármacos; Linfócitos T CD8-Positivos/virologia; Proliferação de Células/efeitos dos fármacos; Criança; Pré-Escolar; Vírus da Dengue/genética; Vírus da Dengue/crescimento & desenvolvimento; Vírus da Dengue/metabolismo; Feminino; Regulação da Expressão Gênica; Antígenos HLA-DR/genética; Antígenos HLA-DR/imunologia; Humanos; Imunidade Celular; Índia; Lactente; Interferon gama/genética; Interferon gama/imunologia; Ionomicina/farmacologia; Masculino; Glicoproteínas de Membrana/genética; Glicoproteínas de Membrana/imunologia; Cultura Primária de Células; RNA Helicases/genética; RNA Helicases/imunologia; Receptores de Antígenos de Linfócitos T/genética; Receptores de Antígenos de Linfócitos T/imunologia; Serina Endopeptidases/genética; Serina Endopeptidases/imunologia; Transdução de Sinais; Subpopulações de Linfócitos T/efeitos dos fármacos; Subpopulações de Linfócitos T/virologia; Acetato de Tetradecanoilforbol/farmacologia; Proteínas não Estruturais Virais/genética; Proteínas não Estruturais Virais/imunologia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Asia Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Asia Idioma: En Ano de publicação: 2016 Tipo de documento: Article